Is the Bentall procedure (CPT 33863) medically necessary for a patient with a 5-5.1cm ascending aortic aneurysm, without significant stenosis or insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is the Bentall Procedure Medically Necessary for a 5.0-5.1cm Ascending Aortic Aneurysm with Bicuspid Aortic Valve?

Yes, the Bentall procedure is medically necessary for this patient with a bicuspid aortic valve and 5.0-5.1cm ascending aortic aneurysm, as current guidelines support surgical intervention at ≥5.0cm for bicuspid aortic valve disease when performed by experienced surgeons. 1, 2

Guideline-Based Surgical Thresholds

The most recent ACC/AHA guidelines (2022) establish clear criteria for surgical intervention in bicuspid aortic valve patients:

  • Surgery is indicated at ≥5.5cm for asymptomatic patients with ascending aortic aneurysms 1
  • Surgery is reasonable at ≥5.0cm when performed by experienced surgeons in a Multidisciplinary Aortic Team 1
  • For bicuspid aortic valve specifically, surgery is recommended at ≥5.0cm diameter 2, 3

The 2024 ESC guidelines similarly recommend surgery at ≥50mm (5.0cm) for bicuspid aortic valve-associated aneurysms 1, which is a lower threshold than the ≥55mm required for tricuspid valves 1.

Why Bicuspid Aortic Valve Warrants Earlier Intervention

Bicuspid aortic valve disease carries inherently higher risk:

  • Patients with bicuspid aortic valve have accelerated aortic wall degeneration and higher dissection risk compared to tricuspid valves 1
  • The "root phenotype" demonstrates more malignant behavior with higher velocity of progression and adverse aortic event rates 1
  • Over 60% of acute type A aortic dissections occur in non-dilated ascending aortas (<5.5cm), emphasizing the risk even at smaller diameters 1

Additional Risk Factors Supporting Surgery

The patient's young age is actually a strong indication for surgery rather than a reason to delay:

  • Young patients have low surgical risk (<1% mortality in experienced centers) and long life expectancy, making early prophylactic surgery favorable 1
  • The risk of dissection increases with time, and waiting until 5.5cm may expose the patient to unnecessary risk during the observation period 1
  • Rapid disease progression is common in bicuspid aortic valve disease, with growth rates potentially exceeding 0.3-0.5cm/year 1, 3

Bentall Procedure Appropriateness

The Bentall procedure (composite valve-graft conduit with coronary reimplantation) is appropriate when:

  • The aortic root is involved in the aneurysmal process 1
  • The patient has bicuspid aortic valve disease affecting both the valve and root 4, 5
  • Experienced surgical teams can achieve <1% operative mortality 1, 6

The procedure requires lifelong anticoagulation with vitamin K antagonists if a mechanical valve prosthesis is used 1. Alternatively, valve-sparing root replacement (David procedure) should be considered in experienced centers to avoid lifelong anticoagulation 1.

Why the MCG Criteria Are Inadequate

The utilization management criteria cited (MCG S-290) focus exclusively on valve dysfunction (stenosis/regurgitation) and completely ignore aortic diameter thresholds for aneurysm disease [@case history@]. This represents a fundamental misunderstanding of surgical indications:

  • Aortic aneurysm surgery is indicated based on diameter and dissection risk, independent of valve function 1, 2
  • The absence of significant stenosis or insufficiency does NOT preclude the need for surgery when aneurysm criteria are met 1, 3
  • Current evidence-based guidelines from ACC/AHA and ESC supersede generic utilization management criteria 1, 2

Common Pitfalls to Avoid

  • Do not wait until 5.5cm in bicuspid aortic valve patients—the threshold is 5.0cm 1, 2, 3
  • Do not conflate valve replacement criteria with aortic aneurysm surgery criteria—these are separate indications 1
  • Do not delay surgery in young, low-risk patients with bicuspid aortic valve at 5.0-5.1cm, as the procedural risk is lower than the cumulative risk of observation 1
  • Ensure measurements are obtained perpendicular to the aortic axis using consistent imaging modalities (CT or MRI preferred over echocardiography for ascending aorta) 3

Surgical Outcomes Data

Published outcomes support early intervention:

  • Hospital mortality for Bentall procedure is 2-5% in contemporary series 6, 5, 7
  • Ten-year survival after Bentall procedure is 74-84% 4, 7
  • Freedom from reoperation at 10 years is 94-95% 7
  • No increased mortality when surgery is performed electively versus emergently for dissection 5

This patient meets Class IIa (reasonable) ACC/AHA criteria and Class I (recommended) ESC criteria for surgical intervention based on bicuspid aortic valve with 5.0-5.1cm ascending aortic aneurysm. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Dilated Aorta

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Dilated Ascending Aorta

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bicuspid aortic valve disease and ascending aortic aneurysm: should an aortic root replacement be mandatory?†.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2016

Research

Three faces of the Bentall procedure.

Journal of cardiac surgery, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.